Global Dental Biomaterials Market Overview
Dental Biomaterials Market Size was prized at USD 5.5 Billion in 2022. The dental biomaterials market industry is projected to grow from USD 5.82 Billion in 2023 to USD 9.21 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.90% during the forecast period (2023 - 2032).
The rises in the incidence of oral illnesses, dental implants becoming more widely used, and dental tourism expansion are the key market drivers fostering the growth of the market. The ongoing R&D efforts done by several competitors are likely to cause the market to expand throughout the course of the forecast period.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Dental Biomaterials Market Trends
- Growing prevalence of dental disorders is driving the market growth
Market CAGR for dental biomaterials is driven by the rising number of dental diseases. The market for dental biomaterials is expected to increase in the near future due to an increase in the prevalence of dental disorders. More than 530 million children have dental caries of their primary teeth, according to World Health Organisation (WHO) estimates from 2020.
Due to rising urbanization and altered living situations, oral illnesses are becoming more common in most low- and middle-income countries. The availability and affordability of meals with a high sugar content, inadequate exposure to fluoride (in the water supply and oral hygiene products like toothpaste), and limited access to oral healthcare services in communities have all increased dental problems. Thus, the rising frequency of dental caries creates profitable opportunities for important competitors to increase their market presence and share, particularly in emerging markets.
Figure 1: Predicted analysis of various dental diseases throughout life
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Dental biomaterials have a huge future in developing nations like China, Japan, India, Brazil, and Singapore. This can be attributed to these countries' growing populations and unmet medical requirements. The market for dental biomaterials in these nations is projected to be driven by a rise in healthcare-related customer expectations due to better economic conditions and higher per capita disposable income. Thanks to dental tourism, manufacturers and distributors should have a lot of opportunities to establish themselves in emerging economies.
The need for restorative dental products is projected to increase as a result. Patients from wealthy nations are traveling abroad for dental care due to these economic advantages. The need for dental materials for restoration has gone up as a result. Thus, driving the dental biomaterials market revenue.
Dental Biomaterials Market Segment Insights
Dental Biomaterials Type Insights
The dental biomaterials market segmentation, based on type, includes metallic biomaterials, ceramic biomaterials, and polymeric biomaterials. In terms of revenue share, the ceramic biomaterials segment dominated the worldwide dental biomaterials market in 2022. Bioceramic materials perform better than other biomaterials in terms of mechanical properties, limited plasticity, poor degradability, high melting temperature, and non-corrosiveness.
February 2022:Ultradent Products Inc introduced MTApex bioceramic root canal sealer, a novel endodontic product that can be utilized with any endodontic obturation process. When delivered with Ultradent's 29 ga Single Sideport NaviTip tip, MTApex bioceramic root canal sealant has an extremely smooth consistency. It also includes a bioceramic sealer that can be used with any endodontic obturation procedure.
During the anticipated period, the dental biomaterials market is anticipated to witness consistently rapid revenue growth in the metallic biomaterials sector. Due to their excellent mechanical, chemical, and biocompatibility, metallic biomaterials have been employed in dentistry and oral surgery for decades.
Dental Biomaterials Application Insights
The dental biomaterials market segmentation, based on application, includes implantology, prosthodontics, and orthodontics. The prosthodontics segment dominated the market, accounting for 51.4% of market revenue (2.8 Billion). Biomaterials substantially impact several prosthetic issues, including the regeneration of tooth pulp, the healing process, and bacterial development and inflammation. The dental implantology segment is anticipated to experience reasonably fast revenue growth in the worldwide dental biomaterials market throughout the forecast period. Recent years have seen a substantial change in treatment options and approaches for achieving the best possible functional and cosmetic outcomes with implant restorations due to the development of dental biomaterials.
Figure 2: Dental Biomaterials Market, by Application, 2022 & 2032 (USD Billion)
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Dental Biomaterials End-User Insights
The dental biomaterials market segmentation, based on end-user, includes dental product manufacturers, dental laboratories, dental hospitals and clinics, and dental academies and research institutes. In terms of revenue, the dental laboratories sector held the greatest market share for dental biomaterials in 2022. Modern technology is available in dental laboratories, and it is becoming more and more popular since it may streamline operations, improve accuracy, and speed up integration and communication with clinics. During the forecast period, the dental biomaterials market is anticipated to witness a notably rapid revenue growth rate in the hospitals and clinics sector. This results from the increased availability of modern, digitally improved equipment and hospitals with complete testing departments.
Dental Biomaterials Regional Insights
By region, the report gives market insights into North America, Europe, Asia-Pacific and Rest of the World. The Asia-Pacific Dental Biomaterials Market area will dominate this market. The Asia-Pacific area has a growing demand for dental biomaterials as tooth and mouth problems become more common. The two most populous nations in the world, China and India, both of which are becoming economic leaders, are located in this region, which is one of the world's most densely inhabited zones. Moreover, China’s dental biomaterials market held the largest market share, and the Indian dental biomaterials market was the rapidly growing market in the region.
Further, the key countries studied in the market report are US, Canada, France, German, Italy, UK, Spain, Japan, China, Australia, India, South Korea, and Brazil.
Figure 3: DENTAL BIOMATERIALS MARKET SHARE BY REGION 2022 (USD Billion)
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
North America’s dental biomaterials market accounts for the second-largest market share. This is brought on by rising governmental spending on oral health, an aging population, and an increase in the use of dental biomaterials in the manufacture of implants and other dental products. Another factor driving industry expansion in this area is the growing number of dental hospitals and clinics. Further, the U.S.A. dental biomaterials market held the major market share, and the Canadian dental biomaterials market was the rapidly growing market in the region.
Europe’s Dental Biomaterials Market is expected to grow at the fastest CAGR from 2023 to 2032. This is linked to escalating government restrictions, significant biotechnology businesses for dental biomaterials clinical development, and rising R&D efforts and government patent approvals. Further, the German dental biomaterials market held the largest market share, and the UK dental biomaterials market was the rapidly growing market in the European region.
Dental Biomaterials Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development to expand their product lines, which will help the dental biomaterials market, grow even more. To increase their worldwide footprint, market participants are also engaging in various strategic actions. Important market developments include introducing new products, mergers and acquisitions, contractual agreements, increased investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the dental biomaterials industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics manufacturers use in the dental biomaterials industry to benefit clients and increase the market sector. In recent years, the dental biomaterials industry has offered some of the most significant medical advantages. Major players in the dental biomaterials market, including Dentsply Sirona, Inc., 3M Company, Geistlich Pharma AG, Straumann Holding AG, Medtronic PLC, and others, are attempting to increase market demand by investing in research and development operations.
SprintRay is a dental technology firm that creates whole 3D printing ecosystems for dentists.SprintRay creates user-friendly, cutting-edge dental solutions such as 3D printers and post-processing environments, 3D printing software with AI technology, and revolutionary 3D resins. Dental care providers may provide best-in-class service using SprintRay's highly-specialized, low-cost technologies. In October 2022, SprintRay Inc. announced the commercial availability of OnX Tough, a cutting-edge hybrid ceramic resin designed for 3D printing dental prostheses. This new resin uses SprintRay's unique NanoFusion technology and provides unprecedented durability and lifelike translucency for high-quality, same-day smiles.
Botiss Biomaterials sells oral tissue regeneration products. Oral tissue regeneration products, such as membranes for directed tissue and bone regeneration, a wide variety of bovine, allogeneic, and synthetic bone-graft materials, and soft-tissue-graft products, are distributed by the company and are utilized in leading clinics around Europe. In August 2021, Botiss Biomaterials GmbH announced the development of next-generation dental biomaterials, including the first-ever dental magnesium biomaterial to achieve CE clearance, providing an option for dentists looking for a mechanically robust biomaterial that would be gradually replaced by natural bone. The introduction of the #NOVAMag® regeneration system gives dentists another alternative for a mechanically strong biomaterial but entirely bioresorbable, eventually being replaced by natural bone.
Key Companies in the dental biomaterials market include
- 3M Company
- Bego Medical GmbH
- Bioceramics B.V.
- Carpenter Technology Corporation
- Danaher Corporation
- Datum Dental Ltd
- Dentsply Sirona, Inc.
- GC Corporation
- Geistlich Pharma AG
- Henry Schein, Inc.
- Ivoclar Vivadent AG
- Keystone Dental, Inc.
- Kuraray Co., Ltd
- Medtronic PLC
- Mitsui Chemicals, Inc.
- Royal DSM
- Straumann Holding AG
- Victrex PLC
- Zimmer Biomet Holdings, Inc.
Dental Biomaterials Industry Developments
April 2022: Sonendo, Inc., a prominent dental technology firm and the creator of the GentleWave System has introduced the CleanFlow treatment equipment. It is intended to be used with Sonendo's GentleWave System, which offers a less painful and invasive alternative to standard root canal therapy.
January 2020: Pulpdent Corporation, a dental research and production firm in the Boston region, debuted its ACTIVA Presto dental material. The new white dental filling material has qualities similar to natural teeth. ACTIVA Presto is a moisture-friendly stackable composite with a unique chemistry that penetrates and integrates with tooth structure for margin-free adaptation.
Dental Biomaterials Market Segmentation
Dental Biomaterials Type Outlook
-
Metallic Biomaterials
-
Ceramic Biomaterials
-
Polymeric Biomaterials
Dental Biomaterials Application Outlook
-
Implantology
-
Prosthodontics
-
Orthodontics
Dental Biomaterials End-User Outlook
-
Dental Product Manufacturers
-
Dental Laboratories
-
Dental Hospitals and Clinics
-
Dental Academies and Research Institutes
Dental Biomaterials Regional Outlook
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Rest of Europe
-
Asia-Pacific
-
China
-
Japan
-
India
-
Australia
-
South Korea
-
Australia
-
Rest of Asia-Pacific
-
Rest of the World
-
Middle East
-
Africa
-
Latin America
| Report Attribute/Metric |
Details |
| Market Size 2022 |
USD 5.5 Billion |
| Market Size 2023 |
USD 5.82 Billion |
| Market Size 2032 |
USD 9.21 Billion |
| Compound Annual Growth Rate (CAGR) |
5.90% (2023-2032) |
| Base Year |
2022 |
| Market Forecast Period |
2023-2032 |
| Historical Data |
2018- 2022 |
| Market Forecast Units |
Value (USD Billion) |
| Report Coverage |
Market Competitive Landscape, Revenue Forecast, Growth Factors, and Trends |
| Segments Covered |
Type, Application, and End-User |
| Geographies Covered |
North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered |
US, Canada, France, German, Italy, UK, Spain, Japan, China, Australia, India, South Korea, and Brazil. |
| Key Companies Profiled |
Dentsply Sirona, Inc., 3M Company, Geistlich Pharma AG, Straumann Holding AG, and Medtronic PLC. |
| Key Market Opportunities |
Shift towards newer materials and products. |
| Key Market Dynamics |
Increasing prevalence of dental disorders |
Dental Biomaterials Market Highlights:
Frequently Asked Questions (FAQ) :
The market size of the dental biomaterials market was prized at USD 5.5 Billion in 2022.
The worldwide market is forecast to expand at a CAGR of 5.90% from 2023 to 2032.
Asia Pacific had the major share of the market.
The key players in the market are Dentsply Sirona, Inc., 3M Company, Geistlich Pharma AG, Straumann Holding AG, and Medtronic PLC.
The ceramic biomaterials category dominated the market in 2022.
The prosthodontics sector had the largest share of the market.
